Results found that overall depression was the most commonly reported adverse event in the VigiBase group while headaches were the most frequent adverse event reported for the Dutch database. Using the ...
The World Health Organization’s (WHO) VigiAccess database lists adverse reactions (ADRs) reported by people after taking a drug or vaccine. It does not confirm that medicinal products or their active ...
Signals of breathing problems may arise when people go on the antiplatelet drug ticagrelor (Brilinta), researchers gathered from safety reports around the world. A search of World Health Organization ...
A disproportionate number of aneurysms and artery dissections were reported among cancer patients on antiangiogenic drugs in a pharmacovigilance study involving more than 1.5 million adverse reactions ...
BOSTON & UPPSALA, Sweden--(BUSINESS WIRE)--March 15, 2004--The UMC (The WHO Foundation Collaborating Centre for International Drug Monitoring) and Lincoln Technologies, Inc. today announced the ...
Last week, the World Health Organization (WHO) boosted its transparency efforts with the launch of a new, open access drug safety database called VigiAccess. The practice of postmarket drug monitoring ...
The World Health Organization’s (WHO) VigiAccess database lists adverse reactions (ADRs) reported by people after taking a drug or vaccine. It does not confirm that medicinal products or their active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results